Adagio Therapeutics Inc (ADGI)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current ADGI market cap is 510.93M. The company's latest EPS is USD -1.8040 and P/E is -2.57.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | |||
| Total Revenue | 0 | 0 | 0 | 0 | 2.26M |
| Operating Income | -53.88M | -43.06M | -76.75M | -46.09M | -49.25M |
| Net Income | -50.23M | -39.44M | -73.65M | -43.5M | -47.25M |
| Year End December 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 |
| Operating Income | -226.91M | -230.66M | -212.76M |
| Net Income | -226.79M | -241.32M | -198.64M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | |||
| Total Assets | 315.41M | 274.92M | 229.18M | 215.47M | 177.35M |
| Total Liabilities | 33.85M | 28.42M | 51.71M | 36.97M | 36.7M |
| Total Equity | 281.56M | 246.5M | 177.47M | 178.5M | 140.64M |
| Year End December 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD ($) | USD ($) | USD ($) | |
| Total Assets | 620.09M | 383.17M | 229.18M |
| Total Liabilities | 62.07M | 27.2M | 51.71M |
| Total Equity | 558.02M | 355.97M | 177.47M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | |||
| Operating | -78.57M | -113.92M | -173.16M | -50.21M | -91.81M |
| Investing | 107.63M | 202.77M | 280.68M | -140k | -140k |
| Financing | 812k | 904k | 1.05M | 39.1M | 39.19M |
| Year End December 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD ($) | USD ($) | USD ($) | |
| Operating | -184.74M | -219.99M | -173.16M |
| Investing | -50.71M | -230.67M | 280.68M |
| Financing | 662.68M | 506k | 1.05M |
| Market Cap | 510.93M |
| Price to Earnings Ratio | -2.57 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 2.55 |
| Price to Book Ratio | 2.88 |
| Dividend Yield | - |
| Shares Outstanding | 110.12M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.22 (4.64%) |
| Company Name | Adagio Therapeutics Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://invivyd.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
